Active Clinical Trials at NGOC

Targeted cutting-edge clinical trials for cancer and blood disorders are available to eligible patients through NGOC’s William S. Gibbons Cancer Research Institute,  a community practice-based clinical trials program serving a primary service area of five counties in Northwest Georgia. Since 1990, the program has grown through the dedication of the physician investigators of the NGOC practice to provide patient access to clinical trials in cancer treatment and support. Services are provided at private physician offices, coordinated by a dedicated staff of clinical research coordinators.

We’re able to attain substantial positive outcomes and save or prolong our patients’ lives by offering access to new cancer therapies available through our affiliations with prestigious cancer organizations, academic institutes and research centers. With participation rates regularly surpassing the national average, the voluntary clinical trials available to eligible NGOC patients offer the most advanced treatments usually only found at large, hospital-based research institutions.

To review active clinical trials at NGOC, please select a disease site listed in the right column. 

The Gibbons Cancer Research Institute is able to support a variety of clinical trials focusing on cancer and blood disorders, particularly in Phases II, III, and IV of investigational drug development.  Available services include on-site blood draw, hematology lab, centrifuge, specimen refrigeration, dedicated IND storage, examination rooms, infusion therapy, and adjacent 24/7 hospital support.

Clinical trials help NGOC cancer doctors, all active investigators registered with the National Cancer Institute, find better ways to prevent, diagnose and treat cancer as part of the nation’s largest cancer research network. Patients can review the varying inclusion criteria with their NGOC oncologist or by visiting

William S. Gibbons Cancer Research Institute
340 Kennestone Hospital Blvd, Suite 200
Marietta, GA 30060
NGOC is grateful to Robert Hermann, MD for his many years of service and care to NGOC patients and his diligence and expertise in building
a robust community-based clinical trial program dedicated to providing the most advanced cancer treatments available.